Higher Corticosteroid Dose Shows No Survival Advantage in Severe HIV-Associated PJP
A retrospective matched-cohort study found no significant survival advantage from higher corticosteroid doses in severe HIV-associated Pneumocystis jirovecii pneumonia.
